在早期出现的尾腺癌中出现PIK3CA突变
Princy Gupta1, Rushabh Gujarathi2, Lu Qiao1
1Department of Surgery, Yale School of Medicine, New Haven, CT.
JCO precision oncology
|February 19, 2026
概括
早期出现的尾癌 (EOAC) 显示出比晚发病的疾病更多的PIK3CA突变. 在尾癌患者中,PIK3CA突变与整体存活率降低有关.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 尾癌 (AC) 影响所有年龄段的患者,其中很大一部分在50岁之前被诊断出来.
- 早期出现的尾癌 (EOAC) 具有独特的特征,表明与晚发作AC (LOAC) 的潜在生物学区别.
- EOAC和LOAC差异的分子基础在很大程度上仍未被探索.
研究的目的:
- 为了比较EOAC和LOAC的突变概况.
- 研究这些分子差异对整体存活时间 (OS) 的影响.
主要方法:
- 从Sloan Kettering-Metastatic Events and Tropisms数据库中对尾腺癌病例的回顾性分析.
- 将患者分为EOAC (<50岁) 和LOAC (≥50岁) 两组.
- 使用美国癌症研究协会基因组学证据瘤信息交换 (GENIE) 项目数据的验证;通过卡普兰-梅尔和考克斯模型进行生存分析.
主要成果:
- 与LOAC患者相比,EOAC患者的PIK3CA突变患病率较高 (17.1%对7.7%).
- 与粘膜性瘤相比,PIK3CA突变在转移性疾病和未经指定腺癌 (NOS) 中更频繁.
- PIK3CA突变独立地与明显更差的整体存活率相关 (HR,2.62;P <.01).
结论:
- 在早期出现的尾癌中,PIK3CA突变更为普遍,并且是较差生存率的独立预测因素.
- 尾癌的预后可能受益于纳入PIK3CA突变状态.
- 抑制PIK3CA的向疗法需要对尾腺癌治疗进行调查.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
15.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
15.0K
Appendicitis-I: Introduction
2.8K
The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
2.8K
The Ras Gene
7.4K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
7.4K
Tumor Progression
7.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K


